These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 37376587)

  • 21. COVID-19 and the Liver: Lessons Learnt from the EAST and the WEST, A Year Later.
    Ekpanyapong S; Bunchorntavakul C; Reddy KR
    J Viral Hepat; 2022 Jan; 29(1):4-20. PubMed ID: 34352133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial injury and COVID-19: Possible mechanisms.
    Babapoor-Farrokhran S; Gill D; Walker J; Rasekhi RT; Bozorgnia B; Amanullah A
    Life Sci; 2020 Jul; 253():117723. PubMed ID: 32360126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmune liver diseases and SARS-CoV-2.
    Sgamato C; Rocco A; Compare D; Minieri S; Marchitto SA; Maurea S; Nardone G
    World J Gastroenterol; 2023 Mar; 29(12):1838-1851. PubMed ID: 37032727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver Injury and Dysfunction Associated with COVID-19: a Review Article.
    Yahia AIO
    Clin Lab; 2022 Jan; 68(1):. PubMed ID: 35023684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential Immunotherapeutic Targets for Hypoxia Due to COVI-Flu.
    Leyfman Y; Erick TK; Reddy SS; Galwankar S; Nanayakkara PWB; Di Somma S; Sharma P; Stawicki SP; Chaudry IH
    Shock; 2020 Oct; 54(4):438-450. PubMed ID: 32649367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoimmune liver disease triggered by SARS-CoV-2: a case report and review of the literature.
    Fanni D; Gerosa C; Serra G; Miglianti M; Coghe F; Van Eyken P; Faa G; La Nasa G; Guido M
    Eur Rev Med Pharmacol Sci; 2024 Feb; 28(4):1632-1638. PubMed ID: 38436196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmune hepatitis after COVID-19 vaccination.
    Zheng H; Zhang T; Xu Y; Lu X; Sang X
    Front Immunol; 2022; 13():1035073. PubMed ID: 36505482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-dependent immune responses in COVID-19-mediated liver injury: focus on cytokines.
    Aghamohamadi N; Shahba F; Zarezadeh Mehrabadi A; Khorramdelazad H; Karimi M; Falak R; Emameh RZ
    Front Endocrinol (Lausanne); 2023; 14():1139692. PubMed ID: 37654571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease.
    Luxenburger H; Thimme R
    Gut; 2023 Sep; 72(9):1783-1794. PubMed ID: 37316169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe acute respiratory syndrome coronavirus 2 causes lung inflammation and injury.
    Wang LL; Yang JW; Xu JF
    Clin Microbiol Infect; 2022 Apr; 28(4):513-520. PubMed ID: 34861410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenetic Mechanisms of Liver-Associated Injuries, Management, and Current Challenges in COVID-19 Patients.
    Naeem M; Bano N; Manzoor S; Ahmad A; Munawar N; Razak SIA; Lee TY; Devaraj S; Hazafa A
    Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2-mediated liver injury: pathophysiology and mechanisms of disease.
    Choaib A; Issa E; El Choueiry F; Eldin JN; Shbaklo K; Alhajj M; Sawaya RT; Assi G; Nader M; Chatila R; Faour WH
    Inflamm Res; 2023 Feb; 72(2):301-312. PubMed ID: 36539655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination.
    Nevola R; Criscuolo L; Beccia D; Delle Femine A; Ruocco R; Imbriani S; Alfano M; Villani A; Russo A; Perillo P; Marfella R; Adinolfi LE; Sasso FC; Marrone A; Rinaldi L
    World J Gastroenterol; 2023 Feb; 29(5):800-814. PubMed ID: 36816617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Case of Fulminant Liver Failure in a 24-Year-Old Man with Coinfection with Hepatitis B Virus and SARS-CoV-2.
    Ali E; Ziglam H; Kohla S; Ahmed M; Yassin M
    Am J Case Rep; 2020 Oct; 21():e925932. PubMed ID: 33046686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19-associated liver injury: Adding fuel to the flame.
    Wang Y; Shen M; Li Y; Shao J; Zhang F; Guo M; Zhang Z; Zheng S
    Cell Biochem Funct; 2023 Dec; 41(8):1076-1092. PubMed ID: 37947373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients.
    Szekanecz Z; Balog A; Constantin T; Czirják L; Géher P; Kovács L; Kumánovics G; Nagy G; Rákóczi É; Szamosi S; Szűcs G; Vályi-Nagy I
    Expert Rev Mol Med; 2022 Mar; 24():e13. PubMed ID: 35311631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
    Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
    J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular and cellular mechanisms of liver dysfunction in COVID-19.
    Huang C; Li Q; Xu W; Chen L
    Discov Med; 2020; 30(160):107-112. PubMed ID: 33382966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 and hepatic injury: cellular and molecular mechanisms in diverse liver cells.
    Ali FEM; Abd El-Aziz MK; Ali MM; Ghogar OM; Bakr AG
    World J Gastroenterol; 2023 Jan; 29(3):425-449. PubMed ID: 36688024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.